| 000 | 01600 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517033840.0 | ||
| 264 | 0 | _c20160714 | |
| 008 | 201607s 0 0 eng d | ||
| 022 | _a1949-2553 | ||
| 024 | 7 |
_a10.18632/oncotarget.4040 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBoland, Genevieve M | |
| 245 | 0 | 0 |
_aClinical next generation sequencing to identify actionable aberrations in a phase I program. _h[electronic resource] |
| 260 |
_bOncotarget _cAug 2015 |
||
| 300 |
_a20099-110 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aHigh-Throughput Nucleotide Sequencing _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aNeoplasms _xgenetics |
| 650 | 0 | 4 |
_aPrecision Medicine _xmethods |
| 700 | 1 | _aPiha-Paul, Sarina A | |
| 700 | 1 | _aSubbiah, Vivek | |
| 700 | 1 | _aRoutbort, Mark | |
| 700 | 1 | _aHerbrich, Shelley M | |
| 700 | 1 | _aBaggerly, Keith | |
| 700 | 1 | _aPatel, Keyur P | |
| 700 | 1 | _aBrusco, Lauren | |
| 700 | 1 | _aHorombe, Chacha | |
| 700 | 1 | _aNaing, Aung | |
| 700 | 1 | _aFu, Siqing | |
| 700 | 1 | _aHong, David S | |
| 700 | 1 | _aJanku, Filip | |
| 700 | 1 | _aJohnson, Amber | |
| 700 | 1 | _aBroaddus, Russell | |
| 700 | 1 | _aLuthra, Raja | |
| 700 | 1 | _aShaw, Kenna | |
| 700 | 1 | _aMendelsohn, John | |
| 700 | 1 | _aMills, Gordon B | |
| 700 | 1 | _aMeric-Bernstam, Funda | |
| 773 | 0 |
_tOncotarget _gvol. 6 _gno. 24 _gp. 20099-110 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.18632/oncotarget.4040 _zAvailable from publisher's website |
| 999 |
_c24937997 _d24937997 |
||